Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Gottschalk

Showing results (71-80 of 227) with videos related to

Pageof 23
Sort By:
Pediatric Hematology and Oncology|August 23, 2011
Highlights of the second international conference on "Immunotherapy in Pediatric Oncology"Christian M Capitini, Stephen Gottschalk, Malcolm Brenner, et al.
Cytotherapy|March 3, 2011
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphomaCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.
Molecular Therapy. Methods & Clinical Development|October 12, 2017
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV ImmunotherapyRobert L Kruse, Thomas Shum, Xavier Legras, et al.
Cancer Research|February 26, 2017
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid TumorsKiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, et al.
Leukemia & Lymphoma|June 7, 2006
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantationCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.
Pediatric Blood & Cancer|December 24, 2022
Allogeneic CD34<sup>+</sup> selected hematopoietic stem cell boost following CAR T-cell therapy in a patient with prolonged cytopenia and active infectionAmanda Lipsitt, Lisa Beattie, Elaine Harstead, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2014
Engager T cells: a new class of antigen-specific T cells that redirect bystander T cellsKota Iwahori, Sunitha Kakarla, Mireya P Velasquez, et al.
Cancer Immunology Research|August 20, 2017
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T CellsMireya Paulina Velasquez, Arpad Szoor, Abishek Vaidya, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapyUluhan Sili, M Helen Huls, Alan R Davis, et al.
Cancer Immunology Research|May 28, 2017
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss VariantsGiedre Krenciute, Brooke L Prinzing, Zhongzhen Yi, et al.
Pageof 23

Showing results (71-80 of 227) with videos related to

Sort By:
Pageof 23
Pediatric Hematology and Oncology|August 23, 2011
Highlights of the second international conference on "Immunotherapy in Pediatric Oncology"Christian M Capitini, Stephen Gottschalk, Malcolm Brenner, et al.
Cytotherapy|March 3, 2011
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphomaCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.
Molecular Therapy. Methods & Clinical Development|October 12, 2017
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV ImmunotherapyRobert L Kruse, Thomas Shum, Xavier Legras, et al.
Cancer Research|February 26, 2017
Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid TumorsKiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, et al.
Leukemia & Lymphoma|June 7, 2006
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantationCatherine M Bollard, Stephen Gottschalk, M Helen Huls, et al.
Pediatric Blood & Cancer|December 24, 2022
Allogeneic CD34<sup>+</sup> selected hematopoietic stem cell boost following CAR T-cell therapy in a patient with prolonged cytopenia and active infectionAmanda Lipsitt, Lisa Beattie, Elaine Harstead, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2014
Engager T cells: a new class of antigen-specific T cells that redirect bystander T cellsKota Iwahori, Sunitha Kakarla, Mireya P Velasquez, et al.
Cancer Immunology Research|August 20, 2017
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T CellsMireya Paulina Velasquez, Arpad Szoor, Abishek Vaidya, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapyUluhan Sili, M Helen Huls, Alan R Davis, et al.
Cancer Immunology Research|May 28, 2017
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss VariantsGiedre Krenciute, Brooke L Prinzing, Zhongzhen Yi, et al.
Pageof 23